SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: MJ who wrote (1255)1/25/1999 11:54:00 AM
From: John S. Baker  Read Replies (1) | Respond to of 1510
 
Distribution, according to my analysis. Also some significant insider selling during November.

But beware that everybody's technical analysis system is different, so "your mileage may vary" <grin>.

Curious about why a broker is calling *you* and asking questions about a stock. Usually, they are full of info and try to get us to *buy*.

JSb.



To: MJ who wrote (1255)1/25/1999 12:57:00 PM
From: Bruce H. Becker  Read Replies (1) | Respond to of 1510
 
MJ

There is no doubt that IMNR is under accumulation, by who, I don't know. I know that the amount of shares owned by institutional investors is up to 29%. End of summer it stood at about 20%, so their is someone, or a grouping of someones buying. On the Yahoo board, someone broke out who owns what shares. You may want to check out that post.

Bruce


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News